A previous report examined 27 patients with HB and demonstrated that CTNNB1 (point mutations and deletion mutations) and AXIN1 (point mutations) gene mutations accounted for 70.4% and 7.4% of the cases, respectively. This evidence concerns the gene CTNNB1 and hemoglobin measurement.